Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma

From WikiCitingRetracted
Revision as of 07:25, 13 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma; G Medolago, G Virotta, A Pita, M Tespiliae; 1992; doi_citing_unknown == Retraction == Simultaneous test of ventricular function and myocardial perfusion during exercise with a new agent labelled with Tc99m ; N Pérez Baliño V Sporn L L Holman A Sosa Liprandi O Masoli A Mitta L Camin S Castiglia K McK; 01/01/1987 ; doi_cited_unknown == Citat...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Target Article[edit | edit source]

Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma; G Medolago, G Virotta, A Pita, M Tespiliae; 1992; doi_citing_unknown

Retraction[edit | edit source]

Simultaneous test of ventricular function and myocardial perfusion during exercise with a new agent labelled with Tc99m  ; N Pérez Baliño V Sporn L L Holman A Sosa Liprandi O Masoli A Mitta L Camin S Castiglia K McK; 01/01/1987

doi_cited_unknown

Citation piece[edit | edit source]

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=Abnormal_uptake_of_technetium-99m_hexakis-2-methoxyisobutylisonitrile_in_a_primary_cardiac_lymphoma&oldid=14771"